KLRK1 and neuroblastoma: In a neuroblastoma xenograft model, NKG2D/CD3ζ-NK cells not only eliminated intratumoral myeloid-derived suppressor cells (MDSCs) with excessive NKG2D ligands but also guided GD2-CAR-T cells to tumor sites (35).